Meloxicam and dexamethasone administration as anti-Inflammatory compounds to sows prior to farrowing does not improve lactation performance

The aim of this experiment was to determine whether administration of an anti-inflammatory compound to sows prior to farrowing would, via reduced pain and inflammation, increase piglet survival and growth. At day 114 of gestation, multiparous sows were randomly allocated to one of the following treatments: Control (n = 43), which received 10 mL saline, NSAID (n = 55) which received 0.4 mg/kg meloxicam and SAID (n = 54) which received 0.1 mg/kg dexamethasone. Treatments were applied again on day 116 if farrowing had not occurred. There was no treatment effect on piglets born alive or dead from parity two to four sows but in those of parity five and older, NSAID administration reduced the number of piglets born alive and increased the number of piglets born dead (p 0.05). Lactation day two plasma concentrations of cortisol, prostaglandin F2 alpha metabolite and haptoglobin did not differ among treatments (p > 0.05). Treatment effects were not observed in liveborn piglet mortality at any age, or litter weight at day 21 (p > 0.05). Average feed intake during lactation was increased by both NSAID and SAID treatments (p = 0.001). The use of meloxicam prior to farrowing should be avoided as it reduced the number of piglets born alive and did not improve piglet survival and growth

Use of bioelectrical impedance spectroscopy to provide a measure of body composition in sows

The ability to accurately estimate fat mass and fat-free mass (FFM) has the potential to improve the way in which sow body condition can be managed in a breeding herd. Bioelectrical impedance spectroscopy (BIS) has been evaluated as a practical technique for assessment of body composition in several livestock species, but similar work is lacking in sows. Bioelectrical impedance uses population-specific algorithms that require values for the apparent resistivities of body fluids and body proportion factors. This study comprised three major aims: (i) to derive apparent resistivity coefficients for extracellular water (ECW) and intracellular water (ICW) required for validation of BIS predictions of total body water (TBW) in live sows against standard reference tracer dilution methods; (ii) to develop predictions of TBW to body composition prediction algorithms, namely FFM, by developing a body geometry correction factor (Kb) and (iii) to compare the BIS predictions of FFM against existing impedance predictors and published prediction equations for use in sows, based on physical measurements of back-fat depth and BW (P2-based predictors). Whole body impedance measurements and the determination of TBW by deuterium dilution and ECW by bromide dilution were performed on 40 Large White x Landrace sows. Mean apparent resistivity coefficients of body fluids were 431.1 Ω.cm for ECW and 1827.8 Ω.cm for ICW. Using these coefficients, TBW and ECW were over-estimated by 6.5 and 3.3%, respectively, compared to measured reference values, although these differences were not statistically different (P > 0.05). Mean Kb was 1.09 ± 0.14. Fat-free mass predictions were 194.9 kg, which equates to 60.9% of total sow weight, and 183.0 kg for BIS and the deuterium dilution method, respectively. Mean differences between the predicted and measured FFM values ranged from − 8.2 to 32.7%, but were not statistically different (P > 0.05). Method validation (leave-one-out procedure) revealed that mean differences between predicted and measured values were not statistically significant (P > 0.05). Of the impedance-based predictors, equivalence testing revealed that BIS displayed the lowest test bias of 11.9 kg (8.2%), although the P2-based prediction equations exhibited the lowest bias and percentage equivalence, with narrow limits of agreement. Results indicate although differences between mean predicted and measured values were not significantly different, relatively wide limits of agreement suggest BIS as an impractical option for assessing body composition in individual sows compared to the use of existing prediction equations based on BW and back fat

Serum creatinine is a poor marker of a predicted change in muscle mass in lactating sows

Serum creatinine (SCr) in humans has proven to be a reliable biomarker of body protein breakdown and/or muscle mass change. This study set out to investigate the potential of SCr to indicate a loss in sow muscle mass over lactation, validated against 3 methyl histidine (3MH) and blood urea nitrogen (BUN), markers of dietary and/or body protein breakdown. A total of 40 sows were allocated to four treatment groups aimed to induce body weight changes by restrictively feeding sows using a stepwise percentage reduction model. Data were pooled and reallocated into three groups representing the 25th, 50th and 75th percentiles based on body weight change over lactation in the range −22.3 to −4.1% (treatment 25), −4.0 to 6.2% (Treatment 50), and 6.3–15.2% (Treatment 75). Indirect measures for the prediction of protein (3MH, BUN) or fat change (caliper, P2) were taken on entry into the farrowing house, day 5 of lactation, and at weaning. Serum was collected on these days, and SCr, 3MH and BUN were analysed. Piglet weaning weight and average daily feed intake did not differ between treatments (p > .05). There were no changes (p > .05) in indirect measures of body composition (sow caliper score, P2) and analytes (SCr, 3MH, BUN) over lactation. By day 20, those sows in treatment 25 had higher (p .05) and did not correlate with SCr change (p > .05) but were highly correlated to BUN change (R2 = 0.691, p < .001). The data suggested that concentrations of SCr and BUN may have been the result of dietary and/or body protein breakdown and/or changes in muscle mass. In the current testing conditions, SCr was not a reliable marker of changes in muscle mass

Does the relationship between sow body composition change in lactation and re-breeding success still exist?

Sow body composition largely reflects the amount of lean and fat tissue stores in the body, and is measured, managed and reported because traditionally when sows mobilise body tissues in lactation to support piglet growth, adverse consequences in subsequent reproduction may be observed. These consequences are largely driven by metabolic changes exerting negative influences on the reproductive axes through luteinising hormone and follicle stimulating hormone and direct impact on the ovary. This results in sows that take longer to ovulate, have lower ovulation rates and shed poorer-quality oocytes, translating to delayed wean to service intervals, higher pregnancy failure and lower litter sizes. Sow management needs to meet both the needs of the piglet (adequate colostrum and milk intake for survival and growth) and the needs of the sow (successful re-breeding). The way pork producers tackle this is through diets designed to match sow requirements at different production stages. We have recently observed, despite efforts (nutritional challenges), that we are unable to induce fat or lean tissue mobilisation in lactating sows, which is a novel finding, although pig populations such as in the EU, UK and USA would appear to be experiencing similar outcomes. Despite our lower reproductive performance than in much of the rest of the world as a consequence of having a closed genetic herd, the specific genetic selection programs that exist within Australia, and the resultant leaner, more efficient sows, may be a potential explanation. This, coupled with the high lactation feed intakes now commonly reported, means that sows are less likely to become catabolic and so suffer from poor re-breeding outcomes. A conclusion from these findings may mean that we now have an opportunity to feed the lactating sow to better meet the growth and survival needs of piglets, with the knowledge that we will not compromise subsequent reproduction